Kezar Life Science (Assuming $14.00 — $16.00 pricing) TICKER / EXCHANGE: KZR listed on the NASDAQ Global Market OFFERING TYPE: IPO OFFERING SIZE: $70.0 million (at mid-point of the range) SHARES OFFERED: 4,666,667 Shares (100% primary) OVER-ALLOTMENT OPTION: 700,000 (100% primary) PRICE RANGE: $14.00 — $16.00 PRO FORMA SHARES OUTSTANDING…

Investment Thesis: Teladoc is the industry leader in comprehensive virtual care delivery. TDOC has a global footprint with significant growth opportunities. Accelerating utilization rates across populations. As of the most recent quarter the company had $786 million in cash, which compared favorably to no short-term debt. Teladoc is a leading…

Investment Thesis: Quest Diagnostics (NYSE: DGX) is a leading global diagnostics company which provides diagnostic testing, information and services, providing insights that enable physicians and other healthcare professionals to make decisions to improve health. Based on DCF valuation, we see a target price at $59 with 50%-55% downside from its…

Investment Thesis: Even in the face of a global pandemic, MSCI’s business is likely to be only modestly affected. The company remains the unquestioned leader in providing global benchmarks to institutional investors. …